# OnCo record stella-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/stella-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "stella-pharma" ;
  schema:name "Stella Pharma"@en ;
  schema:description "Stella Pharma is the Osaka company that developed borofalan (Steboronine), the boron drug approved in Japan in 2020 alongside Sumitomo's accelerator for boron neutron capture therapy of head and neck cancer."@en ;
  schema:url <https://onco.cc/companies/stella-pharma/>, <https://stella-pharma.co.jp/en/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://stella-pharma.co.jp/en/> ;
  onco:tag "machines-wave2" ;
  schema:addressCountry "JP" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/bnct/>, <https://onco.cc/technologies/bnct-accelerator-systems/> .